SUPN vs VNDA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SUPN Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Supernus Pharmaceuticals, Inc. (SUPN) driven by superior Valuation, Growth & Margin, Options & Structure while VNDA counters with relative strength in Momentum & Technical. Fundamentally, SUPN trades at 7.4x Forward P/E with 46.9% operating margin (+13.4% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, SUPN sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SUPN Revenue | VNDA Revenue | SUPN Op. Margin | VNDA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $410M | $190M | 35.3% | 11.3% | SUPN |
| FY2019 | $390M | $230M | 37.8% | 10.0% | SUPN |
| FY2020 | $520M | $250M | 33.4% | 11.0% | SUPN |
| FY2021 | $580M | $270M | 14.8% | 15.7% | VNDA |
| FY2022 | $670M | $250M | 6.9% | 2.5% | SUPN |
| FY2023 | $610M | $190M | -0.9% | -7.2% | SUPN |
| FY2024 | $660M | $200M | 12.3% | -20.5% | SUPN |
| FY2025 | $720M | $220M | -8.7% | -70.0% | SUPN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SUPN | VNDA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.1B | $238.9M | Larger Scale | SUPN |
| Trailing P/E Ratio Valuation | 20.2x | 103.1x | Lower Multiple | SUPN |
| Forward P/E Ratio Valuation | 7.4x | 103.1x | Lower Multiple | SUPN |
| Revenue Growth (YoY) Growth | +13.4% | +24.1% | Higher Growth | VNDA |
| Operating Margin (TTM) Profitability | 46.9% | -77.6% | Higher Margin | SUPN |
| Net Profit Margin Profitability | 32.8% | -119.9% | Higher Margin | SUPN |
| Return on Equity (ROE) Capital Efficiency | -4.2% | -82.5% | Higher ROE | SUPN |
| 52-Week Range Position Momentum | 9% ($26โ$60) | 4% ($4โ$10) | Stronger Trend | SUPN |
| Beta / 30D Volatility Risk Regime | 0.76ฮฒ ยท 125% Vol | 1.25ฮฒ ยท 61% Vol | Lower Realized Risk | VNDA |
| Unified Institutional Score Composite Signal | 51.3 / 100 (HOLD) | 49.0 / 100 (HOLD) | Higher Composite | SUPN |